by Dan Sfera
Dan Sfera aka "The Clinical Trials Guru" shares his thoughts on the clinical research industry, business, entrepreneurship, sports and really just about anything he feels like at the moment
Language
🇺🇲
Publishing Since
11/23/2021
Email Addresses
1 available
Phone Numbers
0 available
April 30, 2025
Dan Sfera analyzes the challenges faced by standalone clinical research sites and explains why adaptation is crucial for their survival in today's evolving landscape.
April 28, 2025
Maya Pudi and Sourabh Dhillon discuss the dilemma of clinical research site owners deciding whether to build their business for a quick sale or for long-term sustainability in an interview with Dan.
April 26, 2025
Dan interviews Ram Yalamanchili, Founder of Tilda Research, about his purchase of a clinical research site network to test his tech, revealing why CROs are panicking in the industry.
vYve & Jim Stengel
Ben Gilbert and David Rosenthal
Matt Abrahams, Think Fast Talk Smart
Society for Clinical Research Sites
The Wall Street Journal & Gimlet
Morning Brew
Debbie and Elyse
STAT
NPR
Hidden Brain, Shankar Vedantam
NPR
Ramit Sethi
Chris Hutchins
Chris Williamson
Gary Vaynerchuk
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.